Bachem Holding
 | |
 Offices in Bubendorf, Switzerland | |
| Type | Stock company |
|---|---|
| SIX: BANB | |
| ISIN | CH0012530207 |
| Industry | Chemicals, biotechnology, pharmaceuticals |
| Founded | 1971 |
| Headquarters | Bubendorf, Switzerland |
| Revenue | CHF 695.1 million[1] (2025) |
Number of employees | 2511[1] |
| Website | bachem |
Bachem Holding AG is a Swiss biotechnology company specializing in the development and manufacture of peptides and complex organic molecules for use as active pharmaceutical ingredients (APIs). The company focuses on peptide-based therapeutics, including large-scale commercial production and process development for pharmaceutical applications. It was founded in 1971 and is a subsidiary of Ingro Finanz AG.[2]
The head office is in Bubendorf in the canton of Basel-Landschaft. Bachem operates production facilities in Vionnaz (Switzerland), Vista and Torrance (United States), and St Helens (United Kingdom), as well as a sales and distribution site in Tokyo.
Bachem is one of the largest manufacturers of peptide-based APIs globally, supplying pharmaceutical and biotechnology companies with products used in both clinical development and commercial therapies.
In recent years, the company has expanded its manufacturing capacity, including new large-scale production facilities in Switzerland and the United States.[1]
At the end of 2025, the company employed 2,511 people, reported revenue of CHF 695.1 million, and net income of CHF 148.8 million.[1]
History
In 2013 the company entered an agreement with GlyTech Inc. to cooperate on the production of glycosylated proteins and peptides.[3]
In 2015 it bought American Peptide, a bio-technology company in Sunnyvale, California.[4]
In the 2020s, Bachem announced and began construction of additional production capacity, including large-scale peptide manufacturing facilities in Bubendorf and the United States.[1]
References
- 1 2 3 4 5 Bachem Annual Report 2025 (PDF) (Report). Bachem Holding AG. 2026.
- ↑ Company Overview of Bachem Holding AG. Bloomberg. Archived 20 June 2018
- ↑ Bachem AG and GlyTech, Inc. Announce Co-promotion Agreement. Accessed February 2023.
- ↑ R.Mullin (2015). "Peptide Manufacturers Stake Out Their Positions"c&en. vol. 93 Issue 17 pp. 16-19. April 27, 2015. Retrieved 19 July 2017.
External links
Media related to Bachem (company) at Wikimedia Commons- Official website